Developer docs
API playgroundTry for free, no card

Search company profiles

Micropore Technologies Ltd.

Full company profile

uuid000jvfm

Namestring
Micropore Technologies Ltd.
Legal namestring
Micropore Technologies Ltd.
Websiteurl
micropore.co.uk
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Micropore Technologies Ltd. is a UK-based process equipment company that develops and sells membrane-based particle engineering technology for the pharmaceutical and drug formulation industry. Its core technology uses patented membranes to produce emulsions, lipid nanoparticles (LNPs), liposomes, PLGA microspheres, and core/shell particle systems with no moving parts, enabling repeatable and reproducible manufacturing at lower energy consumption than traditional routes such as high-pressure homogenisation. The platform serves customers across R&D, pilot, and commercial manufacturing scales, targeting formulation challenges in nucleic acid therapeutics, vaccines, and advanced drug delivery.

The company sells capital equipment under a one-time licence/sales model through a direct enterprise sales motion, with regional contact lines covering Europe/Middle East/Asia and Americas/Canada. Its most recent product, HORIZON, was launched in April 2026 as a next-generation emulsification platform aimed at accelerating scale-up of complex drug formulations from laboratory to commercial production. The company is privately held, headquartered in Teesside, UK (Redcar), with an employee count in the 11-50 range, holds ISO 9001 certification, and operates without disclosed institutional funding, named customers, or partnerships.

The business is differentiated by its membrane-based architecture rather than competing on software, AI, or services. Its competitive moat rests primarily on patented intellectual property and process integration once a customer's formulation is qualified on the platform. The go-to-market is horizontal across multiple formulation applications, with no disclosed evidence of named enterprise customers, recurring revenue streams, or third-party validation, leaving customer concentration, revenue scale, and growth velocity largely opaque from the available data.

Short descriptiontext

Micropore Technologies Ltd. is a UK-based process equipment company that sells patented membrane-based particle engineering technology to pharmaceutical companies for manufacturing lipid nanoparticles, liposomes, PLGA microspheres, and emulsions across R&D, pilot, and commercial scales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRedcar, United Kingdom
HQ citystring
Redcar
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
membrane emulsification equipment, pharmaceutical particle engineering, lipid nanoparticle manufacturing, drug formulation technology, pharmaceutical processing equipment
Industry3 codes
PRIMARYHLAGAHAJ
Crystallization, Particle Engineering & Micronization Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAAAJAI
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYAFAJAKAL
Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
Product category
Pharmaceutical Processing Equipment
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Particle engineering technology systems
TypeOne Time License
Description

Micropore sells its membrane-based particle engineering technology and equipment to pharmaceutical and drug formulation companies. The company serves the full lifecycle from R&D to pilot and commercial manufacturing, suggesting equipment/systems sales as the primary revenue stream.

microporetech.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Micropore Technologies Ltd. develops and supplies membrane-based particle engineering technology and equipment for the pharmaceutical and biotech industries. Its systems produce repeatable, reproducible emulsions and particles — including lipid nanoparticles, liposomes, PLGA microspheres, and core/shell systems — for drug formulation companies across R&D, pilot, and commercial manufacturing stages.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Micropore Technologies Ltd. offers a membrane-based particle engineering platform for the pharmaceutical and biotech industries. The company's core technology enables repeatable, reproducible manufacturing of Lipid Nanoparticles (LNPs), Liposomes, PLGA Microspheres, Core/Shell Systems, and Emulsions. The platform accelerates formulation development from R&D through pilot to commercial-scale manufacturing, with key differentiators including reduced energy consumption, no moving parts for maintenance-free operation, and scalable production. The HORIZON platform represents their next-generation emulsification system for complex drug formulations.

Product and service2 records
1Membrane-Based Particle Engineering Technology
Categorycore product
Description

Patented membrane-based mixing system that produces repeatable and reproducible particles and emulsions with no moving parts, reduced energy consumption, and minimal waste. Sold to pharmaceutical and drug formulation companies for R&D, pilot, and commercial manufacturing.

2HORIZON Emulsification Platform
Categoryproduct platform
Description

Next-generation membrane-based emulsification platform designed to accelerate scale-up of complex drug formulations from lab to commercial production, targeting pharmaceutical and drug development companies needing scalable particle manufacturing.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Micropore Technologies Ltd.

Pharmaceutical Processing Equipmentmicropore.co.uk

Micropore Technologies Ltd. is a UK-based process equipment company that sells patented membrane-based particle engineering technology to pharmaceutical companies for manufacturing lipid nanoparticles, liposomes, PLGA microspheres, and emulsions across R&D, pilot, and commercial scales.

What Micropore Technologies Ltd. does

Micropore Technologies Ltd. is a UK-based process equipment company that develops and sells membrane-based particle engineering technology for the pharmaceutical and drug formulation industry. Its core technology uses patented membranes to produce emulsions, lipid nanoparticles (LNPs), liposomes, PLGA microspheres, and core/shell particle systems with no moving parts, enabling repeatable and reproducible manufacturing at lower energy consumption than traditional routes such as high-pressure homogenisation. The platform serves customers across R&D, pilot, and commercial manufacturing scales, targeting formulation challenges in nucleic acid therapeutics, vaccines, and advanced drug delivery.

The company sells capital equipment under a one-time licence/sales model through a direct enterprise sales motion, with regional contact lines covering Europe/Middle East/Asia and Americas/Canada. Its most recent product, HORIZON, was launched in April 2026 as a next-generation emulsification platform aimed at accelerating scale-up of complex drug formulations from laboratory to commercial production. The company is privately held, headquartered in Teesside, UK (Redcar), with an employee count in the 11-50 range, holds ISO 9001 certification, and operates without disclosed institutional funding, named customers, or partnerships.

The business is differentiated by its membrane-based architecture rather than competing on software, AI, or services. Its competitive moat rests primarily on patented intellectual property and process integration once a customer's formulation is qualified on the platform. The go-to-market is horizontal across multiple formulation applications, with no disclosed evidence of named enterprise customers, recurring revenue streams, or third-party validation, leaving customer concentration, revenue scale, and growth velocity largely opaque from the available data.

Micropore Technologies Ltd. firmographics

Firmographics
Name
Micropore Technologies Ltd.
Legal name
Micropore Technologies Ltd.
Website
https://micropore.co.uk
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
Micropore Technologies Ltd. is a UK-based process equipment company that sells patented membrane-based particle engineering technology to pharmaceutical companies for manufacturing lipid nanoparticles, liposomes, PLGA microspheres, and emulsions across R&D, pilot, and commercial scales.
Ownership category
akta.pro rank

Micropore Technologies Ltd. industry classification

Industry
Product category
Pharmaceutical Processing Equipment
akta.pro industry
PRIMARYHLAGAHAJ
Crystallization, Particle Engineering & Micronization Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAAAJAI
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYAFAJAKAL
Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)

Keywords

  • Membrane emulsification equipment
  • Pharmaceutical particle engineering
  • Lipid nanoparticle manufacturing
  • Drug formulation technology
  • Pharmaceutical processing equipment

Where Micropore Technologies Ltd. is headquartered

Location

Headquarters

HQ city
Redcar
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Micropore Technologies Ltd. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Particle engineering technology systems: Micropore sells its membrane-based particle engineering technology and equipment to pharmaceutical and drug formulation companies. The company serves the full lifecycle from R&D to pilot and commercial manufacturing, suggesting equipment/systems sales as the primary revenue stream.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Micropore Technologies Ltd. product offering

Product offering

Core offering

Micropore Technologies Ltd. develops and supplies membrane-based particle engineering technology and equipment for the pharmaceutical and biotech industries. Its systems produce repeatable, reproducible emulsions and particles — including lipid nanoparticles, liposomes, PLGA microspheres, and core/shell systems — for drug formulation companies across R&D, pilot, and commercial manufacturing stages.

Product overview

Micropore Technologies Ltd. offers a membrane-based particle engineering platform for the pharmaceutical and biotech industries. The company's core technology enables repeatable, reproducible manufacturing of Lipid Nanoparticles (LNPs), Liposomes, PLGA Microspheres, Core/Shell Systems, and Emulsions. The platform accelerates formulation development from R&D through pilot to commercial-scale manufacturing, with key differentiators including reduced energy consumption, no moving parts for maintenance-free operation, and scalable production. The HORIZON platform represents their next-generation emulsification system for complex drug formulations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Membrane-Based Particle Engineering Technology Patented membrane-based mixing system that produces repeatable and reproducible particles and emulsions with no moving parts, reduced energy consumption, and minimal waste. Sold to pharmaceutical and drug formulation companies for R&D, pilot, and commercial manufacturing.
  • HORIZON Emulsification Platform Next-generation membrane-based emulsification platform designed to accelerate scale-up of complex drug formulations from lab to commercial production, targeting pharmaceutical and drug development companies needing scalable particle manufacturing.

Companies that use Micropore Technologies Ltd.

Customer profile

Segments1 record

Ideal customer profiles1 record

Micropore Technologies Ltd. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Micropore Technologies Ltd. partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Micropore Technologies Ltd. competitors and assessment

Company assessment

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Micropore Technologies Ltd. social profiles

Digital presence

Micropore Technologies Ltd. compliance and trust

Trust signal

Compliance1 record

Micropore Technologies Ltd. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Micropore Technologies Ltd. leadership team

Management profile

Number of profiles

Profiles1 record

Micropore Technologies Ltd. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Micropore Technologies Ltd. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Micropore Technologies Ltd.

What does Micropore Technologies Ltd. do?

Micropore Technologies Ltd. develops and supplies membrane-based particle engineering technology and equipment for the pharmaceutical and biotech industries. Its systems produce repeatable, reproducible emulsions and particles — including lipid nanoparticles, liposomes, PLGA microspheres, and core/shell systems — for drug formulation companies across R&D, pilot, and commercial manufacturing stages.

Is Micropore Technologies Ltd. a public or private company?

Micropore Technologies Ltd. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Micropore Technologies Ltd. founded?

Micropore Technologies Ltd. was founded in 2003. It employs 11 to 50 people.

Where is Micropore Technologies Ltd. based?

Micropore Technologies Ltd. is headquartered in Redcar, United Kingdom, in the Europe region.

How does Micropore Technologies Ltd. make money?

One revenue line is on record: particle engineering technology systems.

Does Micropore Technologies Ltd. have an API?

No public API is recorded for Micropore Technologies Ltd..

What industry is Micropore Technologies Ltd. in?

Micropore Technologies Ltd.'s product category is Pharmaceutical Processing Equipment. Its primary akta.pro industry code is HLAGAHAJ, Crystallization, Particle Engineering & Micronization Services, with a secondary code of HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals